Cite
HARVARD Citation
D'Amico, R. et al. (n.d.). 833. Efficacy and Safety of Long-Acting Cabotegravir + Rilpivirine in Participants with HIV/HCV Co-infection: ATLAS-2M 48-Week Results. Open forum infectious diseases. pp. S508-S509. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
D'Amico, R. et al. (n.d.). 833. Efficacy and Safety of Long-Acting Cabotegravir + Rilpivirine in Participants with HIV/HCV Co-infection: ATLAS-2M 48-Week Results. Open forum infectious diseases. pp. S508-S509. [Online].